Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:20 PM
Ignite Modification Date:
2025-12-24 @ 11:20 PM
NCT ID:
NCT04399356
Eligibility Criteria:
Inclusion Criteria:
* Positive SARS-CoV-2 test by PCR
* No requirement of oxygen supplementation
* Ability to take oral medication
Exclusion Criteria:
* Known allergic reactions to any components of Niclosamide medication
* Participation in another trial or use of any experimental treatment for COVID-19, including chloroquine, hydroxychloroquine, remdesivir, and lopinavir/ritonavir
* Hospitalization or requirement of hospitalization at the time of enrollment
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04399356
Study Brief:
Protocol Section:
NCT04399356